ANI PHARMACEUTICALS, INC Preferred Stock Dividends, Income Statement Impact
ANI PHARMACEUTICALS, INC (ANIP) reported Preferred Stock Dividends, Income Statement Impact of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC preferred stock dividends, income statement impact for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC preferred stock dividends, income statement impact for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC preferred stock dividends, income statement impact for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC preferred stock dividends, income statement impact for the quarter ending 2025-09-30 was $344.00K, a 15.27% decline year-over-year.
- ANI PHARMACEUTICALS, INC preferred stock dividends, income statement impact for fiscal 2025 was $1.16M, a 28.80% decline from fiscal 2024.
- ANI PHARMACEUTICALS, INC preferred stock dividends, income statement impact for fiscal 2024 was $1.63M, a 0.00% change from fiscal 2023.
- ANI PHARMACEUTICALS, INC preferred stock dividends, income statement impact for fiscal 2023 was $1.63M, a 0.00% change from fiscal 2022.
- ANI PHARMACEUTICALS, INC preferred stock dividends, income statement impact for fiscal 2022 was $1.63M, a 755.26% increase from fiscal 2021.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 3 month as first filed | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 6 month as first filed | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 9 month as first filed | Preferred Stock Dividends, Income Statement Impact 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $344.00K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $344.00K derived: sum of 3 quarters · filed 2026-05-08 | $751.00K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $344.00K derived: sum of 2 quarters · filed 2026-02-27 | $751.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.16M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $344.00K 10-Q · filed 2025-11-07 | $751.00K derived: sum of 2 quarters · filed 2026-08-07 | $1.16M 10-Q · filed 2025-11-07 | $1.56M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | $407.00K 10-Q · filed 2026-08-07 | $813.00K 10-Q · filed 2026-08-07 | $1.22M derived: sum of 3 quarters · filed 2026-08-07 | $1.63M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $406.00K 10-Q · filed 2026-05-08 | $812.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.22M derived: sum of 3 quarters · filed 2026-05-08 | $1.63M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $812.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.22M derived: sum of 3 quarters · filed 2026-02-27 | $1.63M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $406.00K 10-Q · filed 2025-11-07 | $813.00K derived: sum of 2 quarters · filed 2025-11-07 | $1.22M 10-Q · filed 2025-11-07 | $1.63M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-06-30 | $407.00K 10-Q · filed 2025-08-08 | $813.00K 10-Q · filed 2025-08-08 | $1.22M derived: sum of 3 quarters · filed 2026-02-27 | $1.63M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-03-31 | $406.00K 10-Q · filed 2025-05-09 | $812.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.22M derived: sum of 3 quarters · filed 2026-02-27 | $1.63M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2023-12-31 | $406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $812.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.22M derived: sum of 3 quarters · filed 2026-02-27 | $1.63M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $406.00K 10-Q · filed 2024-11-08 | $813.00K derived: sum of 2 quarters · filed 2024-11-08 | $1.22M 10-Q · filed 2024-11-08 | $1.63M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | $407.00K 10-Q · filed 2024-08-06 | $813.00K 10-Q · filed 2024-08-06 | $1.22M derived: sum of 3 quarters · filed 2025-02-28 | $1.63M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | $406.00K 10-Q · filed 2024-05-10 | $813.00K derived: sum of 2 quarters · filed 2025-02-28 | $1.22M derived: sum of 3 quarters · filed 2025-02-28 | $1.63M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | $407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $813.00K derived: sum of 2 quarters · filed 2025-02-28 | $1.22M derived: sum of 3 quarters · filed 2025-02-28 | $1.63M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | $406.00K 10-Q · filed 2023-11-08 | $813.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.22M 10-Q · filed 2023-11-08 | $1.41M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $407.00K 10-Q · filed 2023-08-09 | $812.00K 10-Q · filed 2023-08-09 | $1.00M derived: sum of 3 quarters · filed 2024-02-29 | $1.00M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $405.00K 10-Q · filed 2023-05-08 | $595.00K derived: sum of 2 quarters · filed 2024-02-29 | $595.00K derived: sum of 3 quarters · filed 2024-02-29 | $595.00K derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $190.00K derived: sum of 2 quarters · filed 2024-02-29 | $190.00K derived: sum of 3 quarters · filed 2024-02-29 | $190.00K 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | |||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | ||||||
| 2015-12-31 | $0.00 10-K · filed 2016-02-23 | ||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $0.00 derived: sum of 2 quarters · filed 2016-02-23 | $0.00 derived: sum of 3 quarters · filed 2016-02-23 | $0.00 10-K · filed 2016-02-23 | |||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | $1.00K derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | $1.00K derived: sum of 3 quarters · filed 2016-02-23 | $1.00K derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | $1.00K derived: sum of 2 quarters · filed 2016-02-23 | $1.00K derived: sum of 3 quarters · filed 2016-02-23 | $2.37M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $1.00K derived: sum of 2 quarters · filed 2016-02-23 | $2.37M derived: sum of 3 quarters · filed 2016-02-23 | $4.97M 10-K · filed 2016-02-23 | |||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-10 | $2.37M derived: sum of 2 quarters · filed 2014-11-10 | $4.97M 10-Q · filed 2014-11-10 | $4.97M 10-Q · filed 2013-11-07 | $7.57M derived: sum of 4 quarters · filed 2014-11-10 | ||
| 2013-06-30 | $2.37M 10-Q · filed 2014-08-07 | $2.37M 10-Q · filed 2013-08-09 | $4.97M 10-Q · filed 2014-08-07 | $4.97M 10-Q · filed 2013-08-09 | $7.57M derived: sum of 3 quarters · filed 2014-08-07 | $10.10M derived: sum of 4 quarters · filed 2014-08-07 | |
| 2013-03-31 | $2.60M 10-Q · filed 2014-05-12 | $5.20M derived: sum of 2 quarters · filed 2014-05-12 | $7.73M derived: sum of 3 quarters · filed 2014-05-12 | $8.87M derived: sum of 4 quarters · filed 2014-05-12 | |||
| 2012-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $5.12M derived: sum of 2 quarters · filed 2014-02-28 | $6.26M derived: sum of 3 quarters · filed 2014-02-28 | $6.92M 10-K · filed 2014-02-28 | |||
| 2012-09-30 | $2.53M 10-Q · filed 2013-11-07 | $3.67M derived: sum of 2 quarters · filed 2013-11-07 | $4.33M 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | $1.14M 10-Q · filed 2013-08-09 | $1.80M 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |